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Involvement in decision making: the devil is in the detail 
   
M. Slade1 highlights that there is superficial, not deep agreement between stakeholders 
about the idea of shared decision making (SDM) in mental health care. To begin to unpack 
why this may be so, it is important to reflect on decision making about what, when and with 
whom. 
Firstly, what kinds of decisions are made in mental health care? They range from life-
changing decisions, sometimes when the person is deemed to no longer have capacity or to 
have reduced capacity to make decisions (e.g., involuntary admission to hospital, medical 
treatment in dementia, starting psychotropic medication) to more routine decisions relating 
to, for example, changing medication, addressing physical health, consent to share 
information, and referral to other services (e.g., drug and alcohol, day opportunities).  
Some decisions require explicitly overriding the patient’s preferences in his/her best 
interest. The danger is that this practice “leaks” into other decisions, due to a cognitive bias 
that people with mental health problems are perceived to be less worthy or capable of being 
involved in decisions when capacity is intact. Hence, it is important to question and safeguard 
our practice against these assumptions. Specific interventions may be required when 
decisional capacity is reduced, e.g., preparing patients in an acute ward for planning talks with 
their psychiatrist to increase their ability to participate in decision making2. 
Secondly, different types of decisions are taken at specific junctures in an illness 
trajectory, e.g. starting a psychotropic medication is a much bigger decision than changing the 
dose of an existing medication. Mental health problems tend to be episodic, so that the ability 
to process information and motivation to participate varies over time. For example, the 
presence of negative symptoms has been found to be associated with less involvement in 
decision making3. 
Thirdly, who is involved in decision making in mental health care? In addition to the 
patient and clinician, carers are frequently involved. Decision making in three-way 
communication, i.e., patient-doctor-carer, is undoubtedly more nuanced and delicate than 
two-way communication. With three people, there is the potential for two people to become 
aligned in support of a particular course of action. This could be the patient and carer (e.g., in 
a bid to reduce or stop medication), or the doctor and carer (e.g., in a bid to increase 
medication or admit the patient), or the doctor and patient (e.g., in a bid to keep the patient 
out of hospital). Sometimes, patients feel that carers are acting as advocates. At other times, 
they feel that carers are working against them with clinicians to make decisions that they do 
not agree with. At all times, clinicians need to gauge the expectations, needs and preferences 
of both parties in a fine balancing act.  
Understanding the extent to which SDM is implemented is intricately linked to how it is 
measured. As Slade points out, “decision making is a complex and dynamic social interaction”1. 
Most research to date, with some notable exceptions4-7,  is based on what people say about 
SDM. Perhaps the most informative means of researching decision making is to record and 
analyse what people do rather than what they say they do. This approach facilitates an 
understanding of the dilemmas faced by both clinicians and patients in situ and the resources 
they deploy to deal with them. It offers a window on how clinicians and patients jointly 
construct the clinical encounter8.  
In an observational study of decision making in outpatient clinics in the UK, involving 
people with a diagnosis of schizophrenia or depression, there was striking variation in the 
extent to which different psychiatrists involved patients in decision making across their 
consultations. Out of a total possible score of 48 using the Observing Patient Involvement 
(OPTION) scale, scores ranged from 0 to 38. The differences in how psychiatrists 
communicated were overwhelmingly explained more by their individual style than by socio-
demographic, structural or clinical factors3. 
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This shows that there is widely varying practice but also some good practice, which can 
be identified and disseminated. It would be interesting to explore what attitudes are 
associated with communication practices that involve patients more in decision making. 
Decision aids are helpful in drawing attention to and focusing discussion on various 
aspects that need to be considered in making a decision. However, they should not detract 
from the clinician-patient interaction, as how decision aids are actually used in interactions is 
important in determining whether they are effective. For example, subtle differences in how 
clinicians ask questions have consequences for what patients say9. This is critical for decision 
making. For example, asking a patient if he/she has questions with the commonly deployed 
“Any questions?” is designed not to elicit any further information, whereas asking “Do you 
have some questions?” is more likely to elicit further discussion. Asking about medication with 
questions such as “No problems with the medication?” invites the patient to confirm that 
there are no problems, making it very difficult for the patient to discuss concerns he/she may 
have and influence subsequent treatment proposals. Clinicians need to be aware of how 
question design shapes patient responses, in order to involve patients in a meaningful rather 
than a superficial way. 
Training clinicians so that they are aware of the subtle differences in how they 
communicate with patients generally, and in decision making specifically, was found to 
improve clinician-patient communication and the therapeutic relationship10. Eliciting the 
patient’s experiences and listening are fundamental: they are the starting point for identifying 
what decisions are made and whether these reflect the patient’s concerns. Working with 
patients to reach a shared understanding of concerns is the first step in identifying what needs 
to be addressed. Addressing this fundamental issue is likely to circumvent some of the 
difficulties that currently undermine SDM in mental health care. 
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